Human Growth Hormone Market in the US 2015-2019

Logo

Naperville, IL -- (SBWire) -- 03/24/2015 --Reportstack, provider of premium market research reports announces the addition of Human Growth Hormone Market in the US 2015-2019 market report to its offering

"[This report is Upcoming for publication on March 25,2015. However you can pre-order this report.]"

About Human Growth Hormone

Human growth hormone, also known as somatotropin, is a peptide with 191 amino acids and 2 sulfhydryl bridges. It is produced by the anterior pituitary, and it is required to attain normal size for children and adolescents. It also has major effects on lipid and carbohydrate metabolism of an individual. The effects of human growth hormone are mainly mediated by IGF-1 and IGF-2. There are two forms of recombinant human growth hormone approved in the market: Somatropin and Somatrem. Somatropin has 191 amino acids and Somatrem contains 192 amino acids. Growth hormone deficiency can occur either due to a damage to the pituitary or the hypothalamus gland, or can also be acquired genetically. Some of the signs of growth hormone deficiency are adiposity, short stature, and hypoglycemia.

Analysts forecast the Human Growth Hormone market in the US to grow at a CAGR of 3.86 percent over the period 2014-2019.

Covered in this Report

This report covers the present scenario and the growth prospects of the Human Growth Hormone market in the US for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of the various human growth hormone drugs available in the US for the treatment of growth hormone deficiency.

Human Growth Hormone Market in the US 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the landscape of the Human Growth Hormone market in the US and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Key Vendors

- F. Hoffmann-La Roche

- Merck Serono

- Novo Nordisk

- Pfizer

Other Prominent Vendors

 - Eli Lilly

- Teva Pharmaceutical

- Novartis

- Ipsen

Market Driver

- Demand for Human Growth Hormone

- For a full, detailed list, view our report

Market Challenge

- High Cost of Therapy

- For a full, detailed list, view our report

Market Trend

- Growing Focus on Needle-free Drug Delivery Devices

- For a full, detailed list, view our report

Key Questions Answered in this Report

- What will the market size be in 2019 and what will the growth rate be?

- What are the key market trends?

- What is driving this market?

- What are the challenges to market growth?

- Who are the key vendors in this market space?

- What are the market opportunities and threats faced by the key vendors?

- What are the strengths and weaknesses of the key vendors?

Complete report is available
http://www.reportstack.com/product/196102/human-growth-hormone-market-in-the-us-2015-2019.html

Contact:
Roger Campbell
roger@reportstack.com
Naperville
Illinois
United States
Ph: 888-789-6604

Media Relations Contact

Salil Modak
Director of Marketing
http://www.reportstack.com

View this press release online at: http://rwire.com/588271